BioSpace News Archive

Natera, Inc. today reported financial results for the third quarter ended September 30, 2021 and provided an update on recent business progress and financial outlook.

Aerie Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2021 and provided a general business update.

Quanterix Corporation today announced financial results for the three months ending September 30, 2021.

Nephros, Inc., a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, announced results for the three months ended September 30, 2021.

CytomX Therapeutics, Inc. today reported third quarter 2021 financial results and provided a business update.

Merus N.V., a clinical-stage oncology company developing innovative, full-length multispecific antibodies, announced the launch of a proposed underwritten public offering of its common shares.

Cardiff Oncology, Inc., a clinical-stage oncology company, developing new precision medicine treatment options for cancer patients in indications with the greatest unmet medical need including KRAS-mutated colorectal cancer, pancreatic cancer, and castrate-resistant prostate cancer, announced recent company highlights and financial results for the third quarter ended September 30, 2021.

Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced financial results for the third quarter ended September 30, 2021.

Glaukos Corporation today announced financial results for the third quarter ended September 30, 2021.

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial results for the third quarter ended September 30, 2021.